** Shares in Fresenius Medical Care FMEG.DE drop 3% in early Frankfurt trade after the world's largest dialysis provider's Q2 results missed market expectations
** Its adjusted operating income for the quarter was 476 million euros ($550 million), missing analysts' forecast of 492 million euros as seen in a company-provided consensus
** Revenue came in at 4.79 billion euros, slightly above analysts' expectation of 4.75 billion euros
** Q2 EBIT, 3% below consensus, was influenced by higher mortality rates and a severe flu season in the U.S., resulting in flat same market treatment growth in the U.S. YOY
** This will be a focus, given that the prior forecast of same market treatment growth above 0.5% was removed, analysts at Jefferies say
** Up to the previous session's close, shares were down 1.9% YTD
($1 = 0.8661 euros)
(Reporting by Isabel Demetz)
((Isabel.demetz@thomsonreuters.com))